|
1
|
Dronedarone in high-risk permanent atrial fibrillation.
|
N Engl J Med
|
2011
|
8.93
|
|
2
|
Brugada syndrome: report of the second consensus conference: endorsed by the Heart Rhythm Society and the European Heart Rhythm Association.
|
Circulation
|
2005
|
8.76
|
|
3
|
ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (writing committee to develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society.
|
Circulation
|
2006
|
5.95
|
|
4
|
ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death).
|
J Am Coll Cardiol
|
2006
|
5.81
|
|
5
|
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC).
|
Eur Heart J
|
2014
|
5.21
|
|
6
|
Short-term versus long-term antiarrhythmic drug treatment after cardioversion of atrial fibrillation (Flec-SL): a prospective, randomised, open-label, blinded endpoint assessment trial.
|
Lancet
|
2012
|
5.00
|
|
7
|
Loss-of-function mutations in the cardiac calcium channel underlie a new clinical entity characterized by ST-segment elevation, short QT intervals, and sudden cardiac death.
|
Circulation
|
2007
|
4.37
|
|
8
|
Short QT Syndrome: a familial cause of sudden death.
|
Circulation
|
2003
|
4.23
|
|
9
|
Proposed diagnostic criteria for the Brugada syndrome: consensus report.
|
Circulation
|
2002
|
3.76
|
|
10
|
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC)Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC).
|
Eur Heart J
|
2015
|
3.70
|
|
11
|
Sudden death associated with short-QT syndrome linked to mutations in HERG.
|
Circulation
|
2003
|
3.68
|
|
12
|
ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society.
|
Europace
|
2006
|
3.11
|
|
13
|
Chronic vagus nerve stimulation: a new and promising therapeutic approach for chronic heart failure.
|
Eur Heart J
|
2010
|
2.86
|
|
14
|
Placebo-controlled, randomized clinical trial of azimilide for prevention of ventricular tachyarrhythmias in patients with an implantable cardioverter defibrillator.
|
Circulation
|
2004
|
2.81
|
|
15
|
Mutations in the cardiac L-type calcium channel associated with inherited J-wave syndromes and sudden cardiac death.
|
Heart Rhythm
|
2010
|
2.79
|
|
16
|
Implantable cardioverter/defibrillator therapy in arrhythmogenic right ventricular cardiomyopathy: single-center experience of long-term follow-up and complications in 60 patients.
|
Circulation
|
2004
|
2.77
|
|
17
|
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC)Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC).
|
Europace
|
2015
|
2.66
|
|
18
|
Short QT syndrome: clinical findings and diagnostic-therapeutic implications.
|
Eur Heart J
|
2006
|
2.59
|
|
19
|
ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death--executive summary: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society.
|
Eur Heart J
|
2006
|
2.54
|
|
20
|
Anterior-posterior versus anterior-lateral electrode positions for external cardioversion of atrial fibrillation: a randomised trial.
|
Lancet
|
2002
|
2.49
|
|
21
|
Brugada syndrome: report of the second consensus conference.
|
Heart Rhythm
|
2005
|
2.48
|
|
22
|
Electromechanical coupling in patients with the short QT syndrome: further insights into the mechanoelectrical hypothesis of the U wave.
|
Heart Rhythm
|
2007
|
2.44
|
|
23
|
Right ventricular involvement in Takotsubo cardiomyopathy.
|
Eur Heart J
|
2006
|
2.28
|
|
24
|
Current electrocardiographic criteria for diagnosis of Brugada pattern: a consensus report.
|
J Electrocardiol
|
2012
|
2.26
|
|
25
|
Sodium channel gene (SCN5A) mutations in 44 index patients with Brugada syndrome: different incidences in familial and sporadic disease.
|
Hum Mutat
|
2003
|
2.24
|
|
26
|
Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulate aortic valve calcification.
|
J Mol Cell Cardiol
|
2004
|
2.23
|
|
27
|
Prognostic value of plasma N-terminal pro-brain natriuretic peptide in patients with severe sepsis.
|
Circulation
|
2005
|
2.20
|
|
28
|
Intrathoracic impedance monitoring, audible patient alerts, and outcome in patients with heart failure.
|
Circulation
|
2011
|
2.17
|
|
29
|
Congenital short QT syndrome and implantable cardioverter defibrillator treatment: inherent risk for inappropriate shock delivery.
|
J Cardiovasc Electrophysiol
|
2003
|
2.14
|
|
30
|
A prospective study on spontaneous fluctuations between diagnostic and non-diagnostic ECGs in Brugada syndrome: implications for correct phenotyping and risk stratification.
|
Eur Heart J
|
2006
|
2.01
|
|
31
|
Is arterial pulse contour analysis using Nexfin a new option in the noninvasive measurement of cardiac output?--A pilot study.
|
J Cardiothorac Vasc Anesth
|
2012
|
2.00
|
|
32
|
Takotsubo cardiomyopathy after systemic consolidation therapy with high-dose intravenous cytarabine in a patient with acute myeloid leukemia.
|
Oncol Res Treat
|
2014
|
1.98
|
|
33
|
Drugs and Brugada syndrome patients: review of the literature, recommendations, and an up-to-date website (www.brugadadrugs.org).
|
Heart Rhythm
|
2009
|
1.92
|
|
34
|
Molecular genetic and functional association of Brugada and early repolarization syndromes with S422L missense mutation in KCNJ8.
|
Heart Rhythm
|
2011
|
1.87
|
|
35
|
Short QT syndrome: pharmacological treatment.
|
J Am Coll Cardiol
|
2004
|
1.87
|
|
36
|
Common variants at SCN5A-SCN10A and HEY2 are associated with Brugada syndrome, a rare disease with high risk of sudden cardiac death.
|
Nat Genet
|
2013
|
1.86
|
|
37
|
Intravenous drug challenge using flecainide and ajmaline in patients with Brugada syndrome.
|
Heart Rhythm
|
2005
|
1.83
|
|
38
|
Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome.
|
J Cardiovasc Electrophysiol
|
2007
|
1.79
|
|
39
|
Long-term prognosis of individuals with right precordial ST-segment-elevation Brugada syndrome.
|
Circulation
|
2005
|
1.78
|
|
40
|
Further insights into the effect of quinidine in short QT syndrome caused by a mutation in HERG.
|
J Cardiovasc Electrophysiol
|
2005
|
1.74
|
|
41
|
Early repolarization pattern is associated with ventricular fibrillation in patients with acute myocardial infarction.
|
Heart Rhythm
|
2012
|
1.71
|
|
42
|
Cardiac autonomic dysfunction in Brugada syndrome.
|
Circulation
|
2002
|
1.68
|
|
43
|
Magnetic resonance imaging findings in patients with Brugada syndrome.
|
J Cardiovasc Electrophysiol
|
2004
|
1.67
|
|
44
|
Matrix-metalloproteinases and their inhibitors are elevated in severe sepsis: prognostic value of TIMP-1 in severe sepsis.
|
Scand J Infect Dis
|
2006
|
1.65
|
|
45
|
Are women with severely symptomatic brugada syndrome different from men?
|
J Cardiovasc Electrophysiol
|
2008
|
1.62
|
|
46
|
Noninvasive determination of cardiac output by the inert-gas-rebreathing method--comparison with cardiovascular magnetic resonance imaging.
|
Cardiology
|
2009
|
1.56
|
|
47
|
Chronic electrical stimulation during the absolute refractory period of the myocardium improves severe heart failure.
|
Eur Heart J
|
2004
|
1.52
|
|
48
|
Takotsubo cardiomyopathy (acute left ventricular apical ballooning syndrome) occurring in the intensive care unit.
|
Intensive Care Med
|
2006
|
1.50
|
|
49
|
Coronary computed tomography and triple rule out CT in patients with acute chest pain and an intermediate cardiac risk profile. Part 1: impact on patient management.
|
Eur J Radiol
|
2012
|
1.50
|
|
50
|
Interleukin-1 beta promotes matrix metalloproteinase expression and cell proliferation in calcific aortic valve stenosis.
|
Atherosclerosis
|
2003
|
1.49
|
|
51
|
Response to intravenous ajmaline: a retrospective analysis of 677 ajmaline challenges.
|
Europace
|
2009
|
1.47
|
|
52
|
Cardiovascular magnetic resonance findings in typical versus atypical forms of the acute apical ballooning syndrome (Takotsubo cardiomyopathy).
|
Int J Cardiol
|
2006
|
1.46
|
|
53
|
Sudden death: do cytokines and prothrombotic peptides contribute to the occurrence of ventricular fibrillation during acute myocardial infarction?
|
Int J Cardiol
|
2009
|
1.43
|
|
54
|
A novel rare variant in SCN1Bb linked to Brugada syndrome and SIDS by combined modulation of Na(v)1.5 and K(v)4.3 channel currents.
|
Heart Rhythm
|
2011
|
1.43
|
|
55
|
Is a narrow and tall QRS complex an ECG marker for sudden death?
|
Heart Rhythm
|
2008
|
1.42
|
|
56
|
Rationale and study design of the increase of vagal tone in heart failure study: INOVATE-HF.
|
Am Heart J
|
2012
|
1.41
|
|
57
|
Induction of ventricular fibrillation rather than ventricular tachycardia predicts tachyarrhythmia recurrences in patients with idiopathic dilated cardiomyopathy and implantable cardioverter defibrillator for secondary prophylaxis.
|
Europace
|
2008
|
1.41
|
|
58
|
Cerebral infarction: incidence and risk factors after diagnostic and interventional cardiac catheterization--prospective evaluation at diffusion-weighted MR imaging.
|
Radiology
|
2005
|
1.40
|
|
59
|
Impact of functional, morphological and clinical parameters on epicardial adipose tissue in patients with coronary artery disease.
|
Circ J
|
2012
|
1.39
|
|
60
|
2015 ESC Guidelines for the Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death.
|
Rev Esp Cardiol (Engl Ed)
|
2016
|
1.39
|
|
61
|
A way to improve the reproducibility of measurements of myocardial velocity gradients.
|
Int J Cardiovasc Imaging
|
2004
|
1.38
|
|
62
|
Who are the long-QT syndrome patients who receive an implantable cardioverter-defibrillator and what happens to them?: data from the European Long-QT Syndrome Implantable Cardioverter-Defibrillator (LQTS ICD) Registry.
|
Circulation
|
2010
|
1.38
|
|
63
|
Inflammatory regulation of extracellular matrix remodeling in calcific aortic valve stenosis.
|
Cardiovasc Pathol
|
2005
|
1.35
|
|
64
|
Volumetric assessment of epicardial adipose tissue with cardiovascular magnetic resonance imaging.
|
Obesity (Silver Spring)
|
2007
|
1.31
|
|
65
|
Long-term follow-up of patients with short QT syndrome.
|
J Am Coll Cardiol
|
2011
|
1.29
|
|
66
|
Diagnostic and prognostic utility of soluble CD 14 subtype (presepsin) for severe sepsis and septic shock during the first week of intensive care treatment.
|
Crit Care
|
2014
|
1.26
|
|
67
|
Clinical and molecular genetics of the short QT syndrome.
|
Curr Opin Cardiol
|
2008
|
1.24
|
|
68
|
Short QT syndrome.
|
Cardiovasc Res
|
2005
|
1.21
|
|
69
|
Expression of bone sialoprotein and bone morphogenetic protein-2 in calcific aortic stenosis.
|
J Heart Valve Dis
|
2004
|
1.20
|
|
70
|
Natural history of small and medium-sized side branches after coronary stent implantation.
|
Am Heart J
|
2002
|
1.20
|
|
71
|
Closing in on the K edge: coronary CT angiography at 100, 80, and 70 kV-initial comparison of a second- versus a third-generation dual-source CT system.
|
Radiology
|
2014
|
1.18
|
|
72
|
A coronary embolus originating from the interatrial septum.
|
Eur Heart J
|
2006
|
1.16
|
|
73
|
Incidence and severity of coronary artery disease in patients with atrial fibrillation undergoing first-time coronary angiography.
|
PLoS One
|
2011
|
1.10
|
|
74
|
Physical activity measured with implanted devices predicts patient outcome in chronic heart failure.
|
Circ Heart Fail
|
2014
|
1.10
|
|
75
|
Tumor necrosis factor alpha promotes an osteoblast-like phenotype in human aortic valve myofibroblasts: a potential regulatory mechanism of valvular calcification.
|
Int J Mol Med
|
2005
|
1.09
|
|
76
|
EHRA/HRS/APHRS expert consensus on ventricular arrhythmias.
|
Heart Rhythm
|
2014
|
1.08
|
|
77
|
Identification and functional characterization of a novel KCNE2 (MiRP1) mutation that alters HERG channel kinetics.
|
J Mol Med (Berl)
|
2002
|
1.05
|
|
78
|
Use of soluble fibrin antigen instead of D-dimer as fibrin-related marker may enhance the prognostic power of the ISTH overt DIC score.
|
Thromb Haemost
|
2004
|
1.05
|
|
79
|
Role of sequence variations in the human ether-a-go-go-related gene (HERG, KCNH2) in the Brugada syndrome.
|
Cardiovasc Res
|
2005
|
1.03
|
|
80
|
Takotsubo cardiomyopathy is not due to plaque rupture: an intravascular ultrasound study.
|
Clin Cardiol
|
2010
|
1.03
|
|
81
|
Systemic and local levels of fetuin-A in calcific aortic valve stenosis.
|
Int J Mol Med
|
2007
|
1.02
|
|
82
|
Extent of late gadolinium enhancement detected by cardiovascular magnetic resonance correlates with the inducibility of ventricular tachyarrhythmia in hypertrophic cardiomyopathy.
|
J Cardiovasc Magn Reson
|
2010
|
1.02
|
|
83
|
The G534E-polymorphism of the gene encoding the factor VII-activating protease is a risk factor for venous thrombosis and recurrent events.
|
Thromb Res
|
2012
|
1.01
|
|
84
|
Significant gender-related differences in radiofrequency catheter ablation therapy.
|
J Am Coll Cardiol
|
2003
|
1.00
|
|
85
|
Clinical characteristics and treatment of short QT syndrome.
|
Expert Rev Cardiovasc Ther
|
2005
|
0.99
|
|
86
|
Prevention of inappropriate ICD shocks in patients with Brugada syndrome.
|
Clin Res Cardiol
|
2009
|
0.98
|
|
87
|
CMR findings in patients with hypertrophic cardiomyopathy and atrial fibrillation.
|
J Cardiovasc Magn Reson
|
2009
|
0.97
|
|
88
|
Fatal inappropriate ICD shock.
|
J Cardiovasc Electrophysiol
|
2007
|
0.97
|
|
89
|
[Guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Executive summary].
|
Rev Esp Cardiol
|
2006
|
0.96
|
|
90
|
In vivo effects of mutant HERG K+ channel inhibition by disopyramide in patients with a short QT-1 syndrome: a pilot study.
|
J Cardiovasc Electrophysiol
|
2007
|
0.96
|
|
91
|
Percutaneous treatment of a coronary aneurysm by stent graft and drug-eluting stent implantation: a potential method to reduce stent graft restenosis.
|
J Interv Cardiol
|
2008
|
0.94
|
|
92
|
Stabilization of monocyte chemoattractant protein-1-mRNA by activated protein C.
|
Thromb Haemost
|
2003
|
0.94
|
|
93
|
Matrix metalloproteinases and their inhibitors: promising novel biomarkers in severe sepsis?
|
Crit Care
|
2009
|
0.94
|
|
94
|
Local paclitaxel delivery after coronary stenting in an experimental animal model.
|
Thromb Haemost
|
2007
|
0.94
|
|
95
|
Endotoxin-induced effects on platelets and monocytes in an in vivo model of inflammation.
|
Basic Res Cardiol
|
2007
|
0.93
|
|
96
|
Management of patients with palpitations: a position paper from the European Heart Rhythm Association.
|
Europace
|
2011
|
0.93
|
|
97
|
Epicardial adipose tissue in patients with heart failure.
|
J Cardiovasc Magn Reson
|
2010
|
0.93
|
|
98
|
Recombinant human activated protein C upregulates cyclooxygenase-2 expression in endothelial cells via binding to endothelial cell protein C receptor and activation of protease-activated receptor-1.
|
Thromb Haemost
|
2005
|
0.92
|
|
99
|
Impact of fibrinogen concentration in severely ill patients on mechanical properties of whole blood clots.
|
Blood Coagul Fibrinolysis
|
2008
|
0.92
|
|
100
|
Can monitoring of intrathoracic impedance reduce morbidity and mortality in patients with chronic heart failure? Rationale and design of the Diagnostic Outcome Trial in Heart Failure (DOT-HF).
|
Eur J Heart Fail
|
2008
|
0.92
|
|
101
|
Global and regional myocardial function quantification by two-dimensional strain in Takotsubo cardiomyopathy.
|
Eur J Echocardiogr
|
2009
|
0.91
|
|
102
|
Coronary artery disease in takotsubo cardiomyopathy.
|
Circ J
|
2007
|
0.91
|
|
103
|
Platelet and monocyte activity markers and mediators of inflammation in Takotsubo cardiomyopathy.
|
Heart Vessels
|
2011
|
0.91
|
|
104
|
Variability of the diagnostic ECG pattern in an ICD patient population with Brugada syndrome.
|
J Cardiovasc Electrophysiol
|
2008
|
0.90
|
|
105
|
Diagnostic and prognostic value of osteopontin in patients with acute congestive heart failure.
|
Eur J Heart Fail
|
2013
|
0.90
|
|
106
|
Effect of freezing method and storage at -20 degrees C and -70 degrees C on prothrombin time, aPTT and plasma fibrinogen levels.
|
Thromb Res
|
2009
|
0.90
|
|
107
|
A novel nonfluoroscopic catheter visualization system (LocaLisa) to reduce radiation exposure during catheter ablation of supraventricular tachycardias.
|
Am J Cardiol
|
2002
|
0.90
|
|
108
|
EHRA/HRS/APHRS expert consensus on ventricular arrhythmias.
|
Europace
|
2014
|
0.90
|
|
109
|
Electric impedance spectroscopy of human atherosclerotic lesions.
|
Atherosclerosis
|
2009
|
0.89
|
|
110
|
Influence of receptor activator of nuclear factor kappa B on human aortic valve myofibroblasts.
|
Exp Mol Pathol
|
2005
|
0.89
|
|
111
|
Endogenous plasma activated protein C levels and the effect of enoxaparin and drotrecogin alfa (activated) on markers of coagulation activation and fibrinolysis in pulmonary embolism.
|
Crit Care
|
2011
|
0.89
|
|
112
|
Differences in twelve-lead electrocardiogram between symptomatic and asymptomatic subjects with short QT interval.
|
Heart Rhythm
|
2008
|
0.89
|
|
113
|
Electrical signals applied during the absolute refractory period: an investigational treatment for advanced heart failure in patients with normal QRS duration.
|
J Am Coll Cardiol
|
2005
|
0.88
|
|
114
|
New devices in heart failure: an European Heart Rhythm Association report: developed by the European Heart Rhythm Association; endorsed by the Heart Failure Association.
|
Europace
|
2013
|
0.88
|
|
115
|
Prospective study of interleukin-6 and the risk of malignant ventricular tachyarrhythmia in ICD-recipients--a pilot study.
|
Cytokine
|
2007
|
0.88
|
|
116
|
Variants of the CYP11B2 gene predict response to therapy with candesartan.
|
Eur J Pharmacol
|
2002
|
0.88
|
|
117
|
Role of proinflammatory markers and NT-proBNP in patients with an implantable cardioverter-defibrillator and an electrical storm.
|
Cytokine
|
2009
|
0.88
|
|
118
|
Cardiovascular response to a modern roller coaster ride.
|
JAMA
|
2007
|
0.87
|
|
119
|
Cumulative experience of azimilide-associated torsades de pointes ventricular tachycardia in the 19 clinical studies comprising the azimilide database.
|
J Am Coll Cardiol
|
2006
|
0.87
|
|
120
|
Transforming growth factor beta 1 (TGF-beta 1) in atrial fibrillation and acute congestive heart failure.
|
Clin Res Cardiol
|
2010
|
0.87
|
|
121
|
Markers of myocardial damage, tissue healing, and inflammation after radiofrequency catheter ablation of atrial tachyarrhythmias.
|
J Cardiovasc Electrophysiol
|
2004
|
0.86
|
|
122
|
Body surface area of ST elevation and the presence of late potentials correlate to the inducibility of ventricular tachyarrhythmias in Brugada syndrome.
|
J Cardiovasc Electrophysiol
|
2002
|
0.86
|
|
123
|
Images in cardiovascular medicine. Yew causes brugada ECG.
|
Circulation
|
2009
|
0.86
|
|
124
|
Impact of shocks on mortality in patients with ischemic or dilated cardiomyopathy and defibrillators implanted for primary prevention.
|
PLoS One
|
2013
|
0.85
|
|
125
|
Alterations of leptin in the course of inflammation and severe sepsis.
|
BMC Infect Dis
|
2012
|
0.85
|
|
126
|
Clinical outcome of patients with diabetes presenting with ST-elevation myocardial infarction and treated with concomitant use of glycoprotein IIb/IIIa inhibitors.
|
Cardiol J
|
2009
|
0.85
|
|
127
|
Channelopathies: Brugada syndrome, long QT syndrome, short QT syndrome, and CPVT.
|
Herz
|
2009
|
0.84
|
|
128
|
CMR scarring in a patient with hypertrophic cardiomyopathy correlates well with histological findings of fibrosis.
|
Eur Heart J
|
2005
|
0.84
|
|
129
|
Effect of atorvastatin on cellular adhesion molecules on leukocytes in patients with normocholesterolemic coronary artery disease.
|
In Vivo
|
2010
|
0.84
|
|
130
|
[Is cardiotoxicity still an issue after breast-conserving surgery and could it be reduced by multifield IMRT?].
|
Strahlenther Onkol
|
2009
|
0.84
|
|
131
|
Exercise tissue Doppler echocardiography with strain rate imaging in healthy young individuals: feasibility, normal values and reproducibility.
|
Int J Cardiovasc Imaging
|
2006
|
0.84
|
|
132
|
Utility of activated partial thromboplastin time waveform analysis for identification of sepsis and overt disseminated intravascular coagulation in patients admitted to a surgical intensive care unit.
|
Crit Care Med
|
2004
|
0.84
|
|
133
|
Activated protein C inhibits the release of macrophage inflammatory protein-1-alpha from THP-1 cells and from human monocytes.
|
Cytokine
|
2004
|
0.84
|
|
134
|
Time-dependent changes in the plasma concentration of matrix metalloproteinase 9 after acute myocardial infarction.
|
Cardiology
|
2003
|
0.84
|
|
135
|
In vivo intravascular electric impedance spectroscopy using a new catheter with integrated microelectrodes.
|
Basic Res Cardiol
|
2004
|
0.84
|
|
136
|
Correlation of degree of aortic valve stenosis by Doppler echocardiogram to quantity of calcium in the valve by electron beam tomography.
|
Am J Cardiol
|
2002
|
0.84
|
|
137
|
Diagnostic performance and cost effectiveness of measurements of plasma N-terminal pro brain natriuretic peptide in patients presenting with acute dyspnea or peripheral edema.
|
Int J Cardiol
|
2008
|
0.83
|
|
138
|
1α,25-dihydroxyvitamin D3 attenuates platelet activation and the expression of VCAM-1 and MT1-MMP in human endothelial cells.
|
Cardiology
|
2011
|
0.83
|
|
139
|
Enhanced expression of platelet CD40-ligand by in vitro lipopolysaccharide-challenge in patients with ventricular fibrillation complicating acute myocardial infarction.
|
Int J Cardiol
|
2006
|
0.83
|
|
140
|
"Responder analysis" for assessing effectiveness of heart failure therapies based on measures of exercise tolerance.
|
J Card Fail
|
2008
|
0.83
|
|
141
|
Drug-induced QT-interval shortening following antiepileptic treatment with oral rufinamide.
|
Heart Rhythm
|
2012
|
0.83
|
|
142
|
Short QT syndrome. Update on a recent entity.
|
Arch Cardiovasc Dis
|
2008
|
0.83
|
|
143
|
Levels of oxidized low-density lipoproteins are increased in patients with severe sepsis.
|
J Crit Care
|
2008
|
0.83
|
|
144
|
Global and regional myocardial function quantification in Takotsubo cardiomyopathy in comparison to acute anterior myocardial infarction using two-dimensional (2D) strain echocardiography.
|
Echocardiography
|
2011
|
0.83
|
|
145
|
The P-selectin gene polymorphism Val168Met: a novel risk marker for the occurrence of primary ventricular fibrillation during acute myocardial infarction.
|
J Cardiovasc Electrophysiol
|
2010
|
0.83
|
|
146
|
[2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy].
|
Kardiol Pol
|
2014
|
0.83
|
|
147
|
Expansion of the Multi-Link Frontier™ coronary bifurcation stent: micro-computed tomographic assessment in human autopsy and porcine heart samples.
|
PLoS One
|
2011
|
0.82
|
|
148
|
Comparison of ventricular tachyarrhythmia characteristics in patients with idiopathic dilated or ischemic cardiomyopathy and defibrillators implanted for primary prevention.
|
Clin Cardiol
|
2011
|
0.82
|
|
149
|
Activation of coagulation during alimentary lipemia under real-life conditions.
|
Int J Cardiol
|
2006
|
0.82
|
|
150
|
Right Ventricular Imaging in 25 Seconds: Evaluating the Use of Sparse Sampling CINE With Iterative Reconstruction for Volumetric Analysis of the Right Ventricle.
|
Invest Radiol
|
2016
|
0.82
|
|
151
|
Effect of atorvastatin on haemostasis, fibrinolysis and inflammation in normocholesterolaemic patients with coronary artery disease: a post hoc analysis of data from a prospective, randomized, double-blind study.
|
Clin Drug Investig
|
2010
|
0.82
|
|
152
|
Prognostic value of platelet-derived growth factor in patients with severe sepsis.
|
Growth Factors
|
2007
|
0.82
|
|
153
|
High plasma levels of tissue inhibitor of metalloproteinase-1 (TIMP-1) and interleukin-8 (IL-8) characterize patients prone to ventricular fibrillation complicating myocardial infarction.
|
Clin Chem Lab Med
|
2007
|
0.82
|
|
154
|
Coronary computed tomography and triple rule out CT in patients with acute chest pain and an intermediate cardiac risk for acute coronary syndrome: part 2: economic aspects.
|
Eur J Radiol
|
2012
|
0.81
|
|
155
|
Extent of myocardial hyperenhancement on late gadolinium-enhanced cardiovascular magnetic resonance correlates with q waves in hypertrophic cardiomyopathy.
|
J Cardiovasc Magn Reson
|
2007
|
0.81
|
|
156
|
No evidence for an association between the rs2824292 variant at chromosome 21q21 and ventricular fibrillation during acute myocardial infarction in a German population.
|
Clin Chem Lab Med
|
2011
|
0.81
|
|
157
|
Increased plasma levels of NT-proANP and NT-proBNP as markers of cardiac dysfunction in septic patients.
|
Clin Lab
|
2005
|
0.81
|
|
158
|
Impact of mitral E/A ratio on the accuracy of different echocardiographic indices to estimate left ventricular end-diastolic pressure.
|
Ultrasound Med Biol
|
2007
|
0.81
|
|
159
|
Statin therapy of calcific aortic stenosis: hype or hope?
|
Eur Heart J
|
2006
|
0.81
|
|
160
|
Advances for treating in-hospital cardiac arrest: safety and effectiveness of a new automatic external cardioverter-defibrillator.
|
J Am Coll Cardiol
|
2003
|
0.81
|
|
161
|
Spontaneous type 1 electrocardiographic pattern is associated with cardiovascular magnetic resonance imaging changes in Brugada syndrome.
|
Heart Rhythm
|
2010
|
0.81
|
|
162
|
Biological relevance of anti-recombinant hirudin antibodies--results from in vitro and in vivo studies.
|
Semin Thromb Hemost
|
2002
|
0.81
|
|
163
|
Delayed hyperenhancement in a case of Takotsubo cardiomyopathy.
|
J Cardiovasc Magn Reson
|
2005
|
0.81
|
|
164
|
The impact of pulmonary disease on noninvasive measurement of cardiac output by the inert gas rebreathing method.
|
Lung
|
2010
|
0.81
|
|
165
|
[Drug-eluting coronary stents and drug eluting balloon catheters: summary of the position papers of the DGK].
|
Clin Res Cardiol
|
2008
|
0.81
|
|
166
|
Sudden cardiac death in a patient with lamin A/C mutation in the absence of dilated cardiomyopathy or conduction disease.
|
Clin Res Cardiol
|
2011
|
0.80
|
|
167
|
Epicardial adipose tissue assessed by cardiac magnetic resonance imaging in patients with heart failure due to dilated cardiomyopathy.
|
Obesity (Silver Spring)
|
2013
|
0.80
|
|
168
|
Detection of a pseudonormal mitral inflow pattern: an echocardiographic and tissue Doppler study.
|
Echocardiography
|
2003
|
0.80
|
|
169
|
IK1 modulates the U-wave: insights in a 100-year-old enigma.
|
Heart Rhythm
|
2008
|
0.80
|
|
170
|
Long-term prognostic value of mid-regional pro-adrenomedullin and C-terminal pro-endothelin-1 in patients with acute myocardial infarction.
|
Clin Chem Lab Med
|
2008
|
0.80
|
|
171
|
Visual estimation of the extent of myocardial hyperenhancement on late gadolinium-enhanced CMR in patients with hypertrophic cardiomyopathy.
|
Magn Reson Imaging
|
2010
|
0.80
|
|
172
|
Side branch occlusion after coronary stent implantation in patients presenting with ST-elevation myocardial infarction: clinical impact and angiographic predictors.
|
Am Heart J
|
2006
|
0.80
|
|
173
|
Point of care coagulation tests in critically ill patients.
|
Semin Thromb Hemost
|
2008
|
0.80
|
|
174
|
Alterations of adiponectin in the course of inflammation and severe sepsis.
|
Shock
|
2012
|
0.80
|
|
175
|
Prevalence of supraventricular tachyarrhythmias in a cohort of 115 patients with Brugada syndrome.
|
Ann Noninvasive Electrocardiol
|
2008
|
0.80
|
|
176
|
Body surface potential mapping in patients with Brugada syndrome: right precordial ST segment variations and reverse changes in left precordial leads.
|
Cardiovasc Res
|
2002
|
0.80
|
|
177
|
Non-invasive evaluation of left ventricular filling pressures in patients with abnormal relaxation.
|
Clin Sci (Lond)
|
2004
|
0.79
|
|
178
|
Radial force and wall apposition of balloon-expandable vascular stents in eccentric stenoses: an in vitro evaluation in a curved vessel model.
|
J Vasc Interv Radiol
|
2002
|
0.79
|
|
179
|
A mobile structure at the entrance of the left atrial appendage in a patient with malignant fibrous histiocytoma.
|
Anadolu Kardiyol Derg
|
2011
|
0.79
|
|
180
|
Low stroke risk after elective cardioversion of atrial fibrillation: an analysis of the Flec-SL trial.
|
Int J Cardiol
|
2013
|
0.79
|
|
181
|
Cellular imaging of human atherosclerotic lesions by intravascular electric impedance spectroscopy.
|
PLoS One
|
2012
|
0.79
|
|
182
|
Incidence and clinical significance of mitral regurgitation in Takotsubo cardiomyopathy.
|
Clin Res Cardiol
|
2009
|
0.79
|
|
183
|
Coagulation activation and expression of CD40 ligand on platelets upon in vitro lipopolysaccharide-challenge in patients with unstable angina.
|
Int J Cardiol
|
2005
|
0.79
|
|
184
|
Electrophysiological characteristics of septal hypertrophy in patients with hypertrophic obstructive cardiomyopathy and moderate to severe symptoms.
|
Circulation
|
2005
|
0.79
|
|
185
|
Recombinant human activated protein C upregulates the release of soluble fractalkine from human endothelial cells.
|
Br J Haematol
|
2006
|
0.78
|
|
186
|
Association of NT-proBNP with severity of heart valve disease in a medical patient population presenting with acute dyspnea or peripheral edema.
|
J Heart Valve Dis
|
2008
|
0.78
|
|
187
|
Catecholaminergic polymorphic ventricular tachycardia and midventricular Takotsubo cardiomyopathy: a novel association?
|
Herzschrittmacherther Elektrophysiol
|
2013
|
0.78
|
|
188
|
Bioimpedance analysis parameters and epicardial adipose tissue assessed by cardiac magnetic resonance imaging in patients with heart failure.
|
Obesity (Silver Spring)
|
2010
|
0.78
|
|
189
|
Platelet and monocyte activation in acute ischemic stroke--is there a correlation with stroke etiology?
|
Clin Appl Thromb Hemost
|
2011
|
0.78
|
|
190
|
Prevalence of atherosclerosis of the coronary and extracranial cerebral arteries in patients undergoing aortic valve replacement for calcified stenosis.
|
J Heart Valve Dis
|
2006
|
0.78
|
|
191
|
A comparative evaluation of electrical velocimetry and inert gas rebreathing for the non-invasive assessment of cardiac output.
|
Clin Res Cardiol
|
2011
|
0.78
|
|
192
|
Midregional pro-atrial natriuretic peptide is a useful indicator for the detection of impaired left ventricular function in patients with coronary artery disease.
|
Int J Cardiol
|
2007
|
0.78
|
|
193
|
Simvastatin and atorvastatin attenuate VCAM-1 and uPAR expression on human endothelial cells and platelet surface expression of CD40 ligand.
|
Cardiol J
|
2012
|
0.78
|
|
194
|
Sex-based differences in clinical and angiographic outcomes in patients with ST-elevation myocardial infarction treated with concomitant use of glycoprotein IIb/IIIa inhibitors.
|
Cardiol J
|
2010
|
0.78
|
|
195
|
Connective tissue growth factor (CTGF/CCN2): diagnostic and prognostic value in acute heart failure.
|
Clin Res Cardiol
|
2013
|
0.78
|
|
196
|
N-terminal pro-atrial natriuretic peptide as a biochemical marker of long-term interventional success after radiofrequency catheter ablation of paroxysmal supraventricular tachyarrhythmias.
|
Clin Chem Lab Med
|
2004
|
0.78
|
|
197
|
Physiological range of mechanical synchronicity of the human heart: comparison between different echocardiographic assessment modalities.
|
Ultrasound Med Biol
|
2005
|
0.78
|
|
198
|
Challenging pacemaker implantation in a patient with acquired dextrocardia after pneumonectomy, skoliosis and complete heart block.
|
Interact Cardiovasc Thorac Surg
|
2010
|
0.78
|
|
199
|
The hidden sepsis marker: aPTT waveform analysis.
|
Thromb Haemost
|
2008
|
0.78
|
|
200
|
Quantitative analysis of coronary plaque composition by dual-source CT in patients with acute non-ST-elevation myocardial infarction compared to patients with stable coronary artery disease correlated with virtual histology intravascular ultrasound.
|
Acad Radiol
|
2013
|
0.78
|
|
201
|
Time course of systemic markers of inflammation in patients presenting with acute coronary syndromes.
|
Clin Chem Lab Med
|
2004
|
0.78
|
|
202
|
Diagnostic performance of mid-regional pro-adrenomedullin as an analyte for the exclusion of left ventricular dysfunction.
|
Int J Cardiol
|
2007
|
0.78
|
|
203
|
A novel regional right ventricular wall-motion abnormality observed in a case of acute pulmonary embolism (reverse McConnell sign).
|
J Am Soc Echocardiogr
|
2005
|
0.78
|
|
204
|
Time-course of neopterin levels in patients suffering from severe sepsis treated with and without Drotrecogin-alpha (activated).
|
Scand J Infect Dis
|
2008
|
0.77
|
|
205
|
Diastolic biventricular impairment at long-term follow-up after atrial switch operation for complete transposition of the great arteries: an exercise tissue Doppler echocardiography study.
|
J Am Soc Echocardiogr
|
2007
|
0.77
|
|
206
|
J-wave syndromes caused by repolarization or depolarization mechanisms a debated issue among experimental and clinical electrophysiologists.
|
J Am Coll Cardiol
|
2010
|
0.77
|
|
207
|
Predictors of electrical storm recurrences in patients with implantable cardioverter-defibrillators.
|
Europace
|
2010
|
0.77
|
|
208
|
Pathogenetic role of Chlamydia pneumoniae in calcific aortic stenosis: immunohistochemistry study and review of the literature.
|
J Heart Valve Dis
|
2003
|
0.77
|
|
209
|
Effects of ethanol on the properties of platelets and endothelial cells in model experiments.
|
World J Cardiol
|
2012
|
0.77
|
|
210
|
Overlapping LQT1 and LQT2 phenotype in a patient with long QT syndrome associated with loss-of-function variations in KCNQ1 and KCNH2.
|
Can J Physiol Pharmacol
|
2010
|
0.77
|
|
211
|
Coagulation activation is associated with interleukin-6 plasma levels in patients with mechanical prosthetic heart valves.
|
In Vivo
|
2006
|
0.77
|
|
212
|
New horizons: NT-proBNP for risk stratification of patients with shock in the intensive care unit.
|
Crit Care
|
2006
|
0.77
|
|
213
|
Modification of the Harris-Benedict equation to predict the energy requirements of critically ill patients during mild therapeutic hypothermia.
|
In Vivo
|
2008
|
0.77
|
|
214
|
Cardiac computed tomographic angiography in patients with acute chest pain and moderately-increased troponin.
|
In Vivo
|
2012
|
0.77
|
|
215
|
Activation of platelets and cellular coagulation in cerebral small-vessel disease.
|
Blood Coagul Fibrinolysis
|
2010
|
0.77
|
|
216
|
[Short QT syndrome].
|
Herz
|
2007
|
0.77
|
|
217
|
Does competitive apnea diving have a long-term risk? Cardiopulmonary findings in breath-hold divers.
|
Clin J Sport Med
|
2005
|
0.77
|
|
218
|
Effect of electrode position on the outcome of cardioversion.
|
Card Electrophysiol Rev
|
2003
|
0.77
|
|
219
|
Guidelines for diagnosis of takotsubo (ampulla) cardiomyopathy.
|
Circ J
|
2007
|
0.76
|
|
220
|
Beyond sepsis: activated protein C and heat stroke.
|
Crit Care Med
|
2006
|
0.76
|
|
221
|
Thrombogenicity of sirolimus-eluting stents and bare metal stents: evaluation in the early phase after stent implantation.
|
In Vivo
|
2010
|
0.76
|
|
222
|
Elevation of the glycoxidation product N(epsilon)-(carboxymethyl)lysine in patients presenting with acute myocardial infarction.
|
Clin Chem Lab Med
|
2009
|
0.76
|
|
223
|
Enhanced coagulation activation by in vitro lipopolysaccharide challenge in patients with ventricular fibrillation complicating acute myocardial infarction.
|
J Cardiovasc Electrophysiol
|
2005
|
0.76
|
|
224
|
Risk stratification in electrical cardiomyopathies.
|
Herz
|
2009
|
0.76
|
|
225
|
Plasminogen activator inhibitor-1 (PAI-1), toll-like receptor 4 (TLR4), factor II (FII), FXIII and fibrinogen polymorphisms are not associated with the prevalence of sudden death due to ventricular fibrillation during myocardial infarction.
|
Clin Chem Lab Med
|
2008
|
0.76
|
|
226
|
Effects of alimentary lipemia and inflammation on platelet CD40-ligand.
|
Thromb Res
|
2007
|
0.76
|
|
227
|
Do we need thrombin generation assays for monitoring anticoagulation?
|
Thromb Haemost
|
2008
|
0.76
|
|
228
|
A hybrid approach for quantification of aortic valve stenosis using cardiac magnetic resonance imaging and echocardiography.
|
J Cardiovasc Magn Reson
|
2005
|
0.75
|
|
229
|
The relationship between the severity of coronary artery disease and epicardial adipose tissue depends on the left ventricular function.
|
PLoS One
|
2012
|
0.75
|
|
230
|
Acidosis and impaired blood coagulation: what and how to correct before using recombinant human factor VIIa.
|
Crit Care Med
|
2007
|
0.75
|
|
231
|
Anti-hirudin antibodies alter pharmacokinetics and pharmacodynamics of recombinant hirudin.
|
Thromb Haemost
|
2003
|
0.75
|
|
232
|
Preventing fatal diagnostic errors: the position of D-dimer assays in the diagnostic procedures for acute chest pain.
|
Crit Care Med
|
2009
|
0.75
|
|
233
|
Thrombin-activatable fibrinolysis inhibitor-a inhibitors: drugs for sepsis or drugs for disseminated intravascular coagulation?
|
Crit Care Med
|
2009
|
0.75
|
|
234
|
Letter regarding article by Franscini et al, "gene expression profiling of inflamed human endothelial cells and influence of activated protein C".
|
Circulation
|
2005
|
0.75
|
|
235
|
From ECG to mutation: programmed ventricular stimulation providing a link to genetics of cardiac channelopathies.
|
Heart Rhythm
|
2011
|
0.75
|
|
236
|
Validation of the peak to mean pressure decrease ratio as a new method of assessing aortic stenosis using the Gorlin formula and the cardiovascular magnetic resonance-based hybrid method.
|
Echocardiography
|
2007
|
0.75
|
|
237
|
Biventricular takotsubo cardiomyopathy in a heart transplant recipient.
|
Circulation
|
2013
|
0.75
|
|
238
|
Determinants of stent expansion in curved stenotic lesions: an in vitro experimental study.
|
J Vasc Interv Radiol
|
2004
|
0.75
|
|
239
|
Alimentary lipemia enhances procoagulatory effects of inflammation in patients with a history of acute myocardial infarction complicated by ventricular fibrillation.
|
Int J Cardiol
|
2007
|
0.75
|
|
240
|
Comparison of long-term prognostic value of N-terminal-proBNP and midregional-pro-adrenomedullin in patients with acute myocardial infarction.
|
Clin Lab
|
2010
|
0.75
|
|
241
|
Factor V Leiden mutation enhances fibrin formation and dissolution in vivo in a human endotoxemia model.
|
Blood
|
2010
|
0.75
|
|
242
|
Utilization of eptifibatide for treatment of severe dissections as a bail-out procedure.
|
Int J Cardiol
|
2004
|
0.75
|
|
243
|
Performance evaluation of a new rapid quantitative assay system for measurement of D-dimer in plasma and whole blood: PATHFAST D-dimer.
|
Thromb Res
|
2006
|
0.75
|
|
244
|
Patient with hypertrophic cardiomyopathy with apical aneurysm and thrombus presenting with progressive congestive heart failure.
|
Hellenic J Cardiol
|
2015
|
0.75
|
|
245
|
Demonstration of heterodimeric fibrinogen molecules partially conjugated with albumin in a novel dysfibrinogen: fibrinogen Mannheim V.
|
Thromb Haemost
|
2009
|
0.75
|
|
246
|
[Clinical relevance of pharmacological challenge in Brugada syndrome].
|
Herzschrittmacherther Elektrophysiol
|
2002
|
0.75
|
|
247
|
Time course of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in patients presenting with acute coronary syndrome.
|
Clin Chem Lab Med
|
2005
|
0.75
|
|
248
|
Chicken's valve in a human heart.
|
Eur Heart J
|
2006
|
0.75
|
|
249
|
Direct versus conventional stent implantation in patients with acute coronary syndrome just before the era of drug-eluting stents.
|
Int J Cardiol
|
2005
|
0.75
|
|
250
|
FFR-Derived From Coronary CT Angiography Using Workstation-Based Approaches.
|
JACC Cardiovasc Imaging
|
2017
|
0.75
|
|
251
|
Heptest-STAT, a new assay for monitoring of low-molecular-weight heparins, is not influenced by pregnancy-related changes of blood plasma.
|
Thromb Haemost
|
2009
|
0.75
|
|
252
|
Is abnormal myocardial repolarization associated with the occurrence of malignant tachyarrhythmias in Takotsubo cardiomyopathy?
|
Cardiol J
|
2013
|
0.75
|
|
253
|
Tackling myocardial metabolism: one year evaluation of free fatty acids, norephinephrine and NT-proBNP in ventricular fibrillation during STEMI.
|
Int J Cardiol
|
2012
|
0.75
|
|
254
|
Electrical alternans in long QT syndrome resembling a Brugada syndrome pattern.
|
Pacing Clin Electrophysiol
|
2003
|
0.75
|
|
255
|
How to measure the right ventricular outflow tract with cardiovascular magnetic resonance imaging: a head-to-head comparison of methods.
|
Hellenic J Cardiol
|
2014
|
0.75
|
|
256
|
Azimilide vs. placebo and sotalol for persistent atrial fibrillation: the A-COMET-II (Azimilide-CardiOversion MaintEnance Trial-II) trial.
|
Eur Heart J
|
2006
|
0.75
|
|
257
|
Variant angina with recurrent ventricular tachycardia successfully treated by stent implantation of a moderate ostial lesion of the right coronary artery.
|
Clin Cardiol
|
2005
|
0.75
|
|
258
|
Severe calcification in left main stem coronary artery stenosis visible on routine chest radiograph.
|
Acta Med Austriaca
|
2004
|
0.75
|
|
259
|
Design of the SHock Inhibition Evaluation with Azimilide (SHIELD) study: a novel method to assess antiarrhythmic drug effect in patients with an implantable cardioverter-defibrillator.
|
Am J Cardiol
|
2005
|
0.75
|
|
260
|
Intercellular adhesion molecule 1 (ICAM-1)--a new substrate for the development of ventricular fibrillation?
|
Int J Cardiol
|
2013
|
0.75
|
|
261
|
[Regular function of the two-chamber ICD's in VDD mode].
|
Dtsch Med Wochenschr
|
2007
|
0.75
|
|
262
|
Assessment of markers of thrombin generation in patients with acute myocardial infarction complicated by ventricular fibrillation.
|
Clin Cardiol
|
2006
|
0.75
|
|
263
|
The reduced anticoagulant effect of fondaparinux at low antithrombin levels.
|
Anesth Analg
|
2009
|
0.75
|
|
264
|
Investigation of platelet adhesiveness in patients with coronary artery disease and acute myocardial infarction using the platelet adhesion assay (PADA).
|
Clin Lab
|
2011
|
0.75
|
|
265
|
Lipoprotein complexed C-reactive protein in patients with coronary heart disease.
|
Thromb Haemost
|
2005
|
0.75
|
|
266
|
Proarrhythmic effect of "reverse mode switch" in a patient with long-QT syndrome.
|
J Cardiovasc Electrophysiol
|
2014
|
0.75
|
|
267
|
Diagnostic and Long-Term Prognostic Value of Sensitive Troponin I in Symptomatic Patients Suspected of Acute Heart Failure.
|
Clin Lab
|
2015
|
0.75
|
|
268
|
Influence of bag volume on reproducibility of inert gas rebreathing pulmonary blood flow measurements in patients with pulmonary diseases.
|
Lung
|
2013
|
0.75
|
|
269
|
β-Blockers and Outcome After Acute Myocardial Infarction.
|
J Am Coll Cardiol
|
2017
|
0.75
|
|
270
|
[2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac Death. The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology].
|
G Ital Cardiol (Rome)
|
2016
|
0.75
|
|
271
|
First report on the effect of thrombin and factor Xa on cardiomyocytes in a three-dimensional cell culture model.
|
Thromb Res
|
2008
|
0.75
|
|
272
|
Predictors of long-term success after catheter ablation of atriofascicular accessory pathways.
|
Heart Rhythm
|
2011
|
0.75
|
|
273
|
A novel noninvasive ultrasonic cardiac output monitor: comparison with cardiac magnetic resonance.
|
Clin Cardiol
|
2010
|
0.75
|
|
274
|
Influence of electrode positioning on accuracy and reproducibility of electrical velocimetry cardiac output measurements.
|
Physiol Meas
|
2016
|
0.75
|
|
275
|
Automatic camera-based identification and 3-D reconstruction of electrode positions in electrocardiographic imaging.
|
Biomed Tech (Berl)
|
2014
|
0.75
|
|
276
|
Evaluation of aortic valve stenosis using a hybrid approach of Doppler echocardiography and inert gas rebreathing.
|
In Vivo
|
2012
|
0.75
|
|
277
|
Non-invasive determination of cardiac output: comparison of a novel CW Doppler ultrasonic technique and inert gas rebreathing.
|
Int J Cardiol
|
2008
|
0.75
|
|
278
|
Drotrecogin alfa (activated) prolongs half-life time of messenger RNA encoding for interleukin-8 and monocyte chemoattractant protein-1.
|
Thromb Haemost
|
2003
|
0.75
|
|
279
|
Utility of combined parameters of common carotid intima-media thickness or albuminuria in diagnosis of coronary artery disease in women.
|
Int J Cardiol
|
2005
|
0.75
|
|
280
|
Reduction of ventricular tachyarrhythmia by treatment of atrial fibrillation in ICD patients with dual-chamber implantable cardioverter/defibrillators capable of atrial therapy delivery: the REVERT-AF Study.
|
Europace
|
2007
|
0.75
|
|
281
|
Novel surface ECG criteria for differentiation between left- and right-sided manifest inferoseptal accessory pathways.
|
Int J Cardiol
|
2008
|
0.75
|
|
282
|
[2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death].
|
Kardiol Pol
|
2015
|
0.75
|
|
283
|
Detection of myocardial ischemia by automated, motion-corrected, color-encoded perfusion maps compared with visual analysis of adenosine stress cardiovascular magnetic resonance imaging at 3 T: a pilot study.
|
Invest Radiol
|
2013
|
0.75
|
|
284
|
Hormone Status Correlates With Incidence of Heart Failure.
|
J Am Coll Cardiol
|
2017
|
0.75
|
|
285
|
[Chlamydia pneumoniae--a new risk factor for calcific aortic stenosis?].
|
Med Klin (Munich)
|
2005
|
0.75
|
|
286
|
Sudden cardiac death in the young: how can disease recognition and prevention in family members be improved?
|
Herzschrittmacherther Elektrophysiol
|
2012
|
0.75
|
|
287
|
Course of indicators of thrombin activity in the early phase of acute myocardial infarction: effect of fibrinolytic therapy and acute percutaneous coronary angioplasty.
|
Thromb Haemost
|
2003
|
0.75
|
|
288
|
Arrhythmias: a ‘Schwartz score’ for short QT syndrome.
|
Nat Rev Cardiol
|
2011
|
0.75
|
|
289
|
Effects of nicotinic acid on endothelial cells and platelets.
|
Cardiovasc Pathol
|
2011
|
0.75
|
|
290
|
Midregional pro-atrial natriuretic peptide: a novel marker of myocardial fibrosis in patients with hypertrophic cardiomyopathy.
|
Int J Cardiovasc Imaging
|
2010
|
0.75
|
|
291
|
Comparison of clinical, angiographic, and intravascular ultrasound parameters after direct stenting versus predilation.
|
Am J Cardiol
|
2003
|
0.75
|
|
292
|
Enhanced proinflammatory response of mononuclear cells to in vitro LPS-challenge in patients with ventricular fibrillation in the setting of acute myocardial infarction.
|
Cytokine
|
2008
|
0.75
|
|
293
|
Galectin-3 Reflects Left Atrial Function being Assessed by Cardiac Magnetic Resonance Imaging.
|
Clin Lab
|
2017
|
0.75
|